Literature DB >> 8277825

Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of optical isomers of ether and thioether lipids.

C I Hong1, S H An, A Nechaev, A J Kirisits, R Vig, C R West.   

Abstract

Four 1-beta-D-arabinofuranosylcytosine conjugates (ara-C) (1a, b and 2a, b) of sn-1 and sn-3 isomers of 1-O-octadecyl-2-O-palmitoylglycerol and its 1-S-alkyl analogue have been synthesized, and their antitumor activity against L1210 lymphoid leukemia in mice were compared with those of the previous conjugates (3a, b) of racemates in order to determine the significance of chirality of the glycerol moieties for activity. Administration (i.p.) of a single dose (300 mg/kg) of conjugates of sn-1 (1a), sn-3 (2a) and rac (3a) isomers of the ether lipid increased lifespan of i.p. implanted L1210 lymphoid leukemic DBA/2J mice by 169, 175 and 236%, respectively. The sn-1 (1b), sn-3 (2b), and rac (3b) isomers of the thioether lipid with a single dose of 300 mg/kg produced an increase in lifespan values of 238, 263 and 250%, respectively. The results indicate that chirality of the glycerol moieties appears not to be critical for the activity, and racemates 3a and 3b are promising prodrugs of ara-C for further clinical investigations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8277825     DOI: 10.1007/bf02537125

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

1.  Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.

Authors:  C I Hong; S H An; L Schliselfeld; D J Buchheit; A Nechaev; A J Kirisits; C R West
Journal:  J Med Chem       Date:  1988-09       Impact factor: 7.446

2.  The synthesis, characterization, and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-dipalmitin.

Authors:  M MacCoss; E K Ryu; T Matsushita
Journal:  Biochem Biophys Res Commun       Date:  1978-11-29       Impact factor: 3.575

3.  Therapeutic activity of a thioether-lipid conjugate of 1-beta-D-arabinofuranosylcytosine in human colorectal cancer xenografts.

Authors:  R Herrmann; W E Berdel
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

4.  Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients.

Authors:  D B Herrmann; H A Neumann; W E Berdel; M E Heim; M Fromm; D Boerner; U Bicker
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

5.  Nucleoside conjugates as potential antitumor agents. 2. Synthesis and biological activity of 1-(beta-D-arabinofuranosyl)cytosine conjugates of prednisolone and prednisone.

Authors:  C I Hong; A Nechaev; C R West
Journal:  J Med Chem       Date:  1979-11       Impact factor: 7.446

6.  Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.

Authors:  W E Berdel; M Fromm; U Fink; W Pahlke; U Bicker; A Reichert; J Rastetter
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

7.  Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.

Authors:  C I Hong; R J Bernacki; S W Hui; Y Rustum; C R West
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

8.  Phospholipid-nucleoside conjugates. 5. The interaction of selected 1-beta-D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-diacylglycerols with serum lipoproteins.

Authors:  M MacCoss; J J Edwards; P Lagocki; Y E Rahman
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

9.  Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids.

Authors:  C I Hong; A J Kirisits; A Nechaev; D J Buchheit; C R West
Journal:  J Med Chem       Date:  1990-05       Impact factor: 7.446

10.  1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.

Authors:  C I Hong; A J Kirisits; D J Buchheit; A Nechaev; C R West
Journal:  Cancer Drug Deliv       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.